findmyKOL
Clinical trialNCT06958861Not, yet, recruitingPhase 2Interventional

A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis

SponsorShanghai Huilun Pharmaceutical Co., Ltd.Enrollment180Acute Exacerbations of Bronchiectasis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Fuyang Hospital of Anhui Medical University

    Fuyang, Anhui, China

    Lei Zhao
  • Hefei First People'S Hospital

    Hefei, Anhui, China

    Zhen Ding
  • Fujian Medical University Union Hospital

    Fuzhou, Fujian, China

    Xiangqi Chen
  • the First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China

    Nanshan ZhongWeijie Guan
  • Peking University Shenzhen Hospital

    Shenzhen, Guangdong, China

    Ruilin Sun
  • Affiliated Hospital of Youjiang Medical University for Nationalities

    Baise City, Guangxi, China

    Yujie Jiang
  • Hebei General Hospital

    Shijiazhuang, Hebei, China

    Li Yan
  • Nanyang Second General Hospital

    Nanyang, Henan, China

    Fengling Ju
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

    Xiaorong Wang
  • Yichang Central People'S Hospital

    Yichang, Hubei, China

    Xinyu Song
  • the Second Xiangya Hospital of Central South University

    Changsha, Hunan, China

    Hong Luo
  • Changzhou First People'S Hospital

    Changzhou, Jiangsu, China

    Chong Li
  • Jiujiang No.1 People'S Hospital

    Jiujiang, Jiangxi, China

    Jun Li
  • Sichuan Provincial People'S Hospital

    Chengdu, Sichuan, China

    Lingyun Gao
  • Deyang People'S Hospital

    Deyang, Sichuan, China

    Chunfang Zeng
  • Hangzhou First People'S Hospital

    Hangzhou, Zhejiang, China

    Limin Wang
  • Jinhua Municipal Central Hospital

    Jinhua, Zhejiang, China

    Dan Zhu
  • Ningbo No.2 Hospital

    Ningbo, Zhejiang, China

    Zhaoxing Dong
  • the First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, China

    Xiaoying Huang

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2025
Primary completion
31 May 2027
Completion
31 May 2027
Last update posted
9 May 2025
Registered enrollment
180
Registry id
NCT06958861

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.